Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines
3 Mar 2017
Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple myeloma
Monoclonal antibodies in multiple myeloma
Treatment options for newly diagnosed multiple myeloma and management of bone disease: Roundtable at IMW 2017
Promising myeloma agents in phase II trials
Examining strategies to tailor multiple myeloma immunotherapy
Antibodies in haemato-oncology
CAR T cells in leukaemia
Stem cell transplant for geriatric ALL
Next steps for treating breast cancer
Cimavax - a lung cancer vaccine
Existing and prospective immunotherapeutics for biliary tract cancer